REQUEST A DEMO
Total
USD $0.00
Search more companies

Cronex. Co. Ltd. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Cronex. Co. Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the manufacture of species. The Company s product portfolio consists of species including mini pigs and others. The Company is a contract research organization (CRO). The Company also researches and develops medicines. The Company was founded on May 1, 2012. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on December 28, 2015.

Headquarters
Juseok-Ro 778Beon-Gil, Paltan-Myeon
Hwaseong; Gyeonggi;

Contact Details: Purchase the Cronex. Co. Ltd. report to view the information.

Website: http://www.cronex.co.kr

Basic Information
Total Employees:
Purchase the Cronex. Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Cronex. Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Cronex. Co. Ltd. report to view the information.
Incorporation Date:
2012
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
크로넥스㈜
Company Performance
Financial values in the chart are available after Cronex. Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
3.28%
Total operating revenue
3.43%
Operating profit (EBIT)
81.78%
EBITDA
92.85%
Net Profit (Loss) for the Period
52.79%
Total assets
-2.82%
Total equity
-29.35%
Operating Profit Margin (ROS)
33.18%
Net Profit Margin
34.73%
Return on Equity (ROE)
26.26%
Debt to Equity Ratio
126.94%
Quick Ratio
-0.08%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?